Document:

EX-10.11

 Exhibit 10.11 

NEURONETICS, INC. 

FORM OF 2018 EMPLOYEE STOCK PURCHASE PLAN 

ADOPTED BY THE BOARD OF
DIRECTORS:                    , 2018 

APPROVED BY THE
STOCKHOLDERS:                    , 2018 
  

	1.    GENERAL;	PURPOSE. 

 (a)    The Plan provides a means by
which Eligible Employees of the Company and certain designated Related Corporations may be given an opportunity to purchase shares of Common Stock. The Plan permits the Company to grant a series of Purchase Rights to Eligible Employees under an
Employee Stock Purchase Plan. 
 (b)    The Company, by means of the Plan, seeks to retain the services of such
Employees, to secure and retain the services of new Employees and to provide incentives for such persons to exert maximum efforts for the success of the Company and its Related Corporations. 

 

	2.    ADMINISTRATION.	

 (a)    The Board will administer the Plan unless and until
the Board delegates administration of the Plan to a Committee or Committees, as provided in Section 2(c). References herein to the Board shall be deemed to refer to the Committee where such administration has been delegated. 

(b)    The Board will have the power, subject to, and within the limitations of, the express provisions of the
Plan: 
 (i)    To determine how and when Purchase Rights will be granted and the provisions of each Offering
(which need not be identical). 
 (ii)    To designate from time to time which Related Corporations of the
Company will be eligible to participate in the Plan. 
 (iii)    To construe and interpret the Plan and Purchase
Rights, and to establish, amend and revoke rules and regulations for its administration. The Board, in the exercise of this power, may correct any defect, omission or inconsistency in the Plan, in a manner and to the extent it deems necessary or
expedient to make the Plan fully effective. 
 (iv)    To settle all controversies regarding the Plan and
Purchase Rights granted under the Plan. 
 (v)    To suspend or terminate the Plan at any time as provided in
Section 12. 
 (vi)    To amend the Plan at any time as provided in Section 12. 

 (vii)    Generally, to exercise such powers and to perform such acts
as it deems necessary or expedient to promote the best interests of the Company and its Related Corporations and to carry out the intent that the Plan be treated as an Employee Stock Purchase Plan. 

(viii)    To adopt such rules, procedures and sub-plans relating to the
operation and administration of the Plan as are necessary or appropriate under applicable local laws, regulations and procedures to permit or facilitate participation in the Plan by Employees who are foreign nationals or employed or located outside
the United States. 
 (c)    The Board may delegate some or all of the administration of the Plan to a Committee
or Committees. If administration is delegated to a Committee, the Committee will have, in connection with the administration of the Plan, the powers theretofore possessed by the Board that have been delegated to the Committee, including the power to
delegate to a subcommittee any of the administrative powers the Committee is authorized to exercise (and references in this Plan to the Board will thereafter be to the Committee or subcommittee), subject, however, to such resolutions, not
inconsistent with the provisions of the Plan, as may be adopted from time to time by the Board. The Board may retain the authority to concurrently administer the Plan with the Committee and may, at any time, revest in the Board some or all of the
powers previously delegated. Whether or not the Board has delegated administration of the Plan to a Committee, the Board will have the final power to determine all questions of policy and expediency that may arise in the administration of the Plan.

 (d)    All determinations, interpretations and constructions made by the Board in good faith will not be
subject to review by any person and will be final, binding and conclusive on all persons. 
  

	3.	SHARES OF COMMON STOCK SUBJECT TO THE PLAN. 

(a)    Subject to the provisions of Section 11(a) relating to Capitalization Adjustments, the maximum number of
shares of Common Stock that may be issued under the Plan will not exceed [            ] shares of Common Stock, plus the number of shares of Common Stock that are automatically added on
January 1st of each year for a period of up to ten years, commencing on the first January 1 following the year in which the IPO Date occurs and ending on (and including) January 1, 2028,
in an amount equal to the lesser of (i)         % of the total number of shares of Capital Stock outstanding on December 31st of the preceding calendar
year, and (ii) [            ] shares of Common Stock. Notwithstanding the foregoing, the Board may act prior to the first day of any calendar year to provide that there will be no January 1st increase in the share reserve for such calendar year or that the increase in the share reserve for such calendar year will be a lesser number of shares of Common Stock than would otherwise occur
pursuant to the preceding sentence. 
 (b)    If any Purchase Right granted under the Plan terminates without
having been exercised in full, the shares of Common Stock not purchased under such Purchase Right will again become available for issuance under the Plan. 

(c)    The stock purchasable under the Plan will be shares of authorized but unissued or reacquired Common Stock,
including shares repurchased by the Company on the open market. 

  
 2 

	4.	GRANT OF PURCHASE RIGHTS; OFFERING. 

(a)    The Board may from time to time grant or provide for the grant of Purchase Rights to Eligible Employees under
an Offering (consisting of one or more Purchase Periods) on an Offering Date or Offering Dates selected by the Board. Each Offering will be in such form and will contain such terms and conditions as the Board will deem appropriate, and will comply
with the requirement of Section 423(b)(5) of the Code that all Employees granted Purchase Rights will have the same rights and privileges. The terms and conditions of an Offering shall be incorporated by reference into the Plan and treated as
part of the Plan. The provisions of separate Offerings need not be identical, but each Offering will include (through incorporation of the provisions of this Plan by reference in the document comprising the Offering or otherwise) the period during
which the Offering will be effective, which period will not exceed 27 months beginning with the Offering Date, and the substance of the provisions contained in Sections 5 through 8, inclusive. 

(b)    If a Participant has more than one Purchase Right outstanding under the Plan, unless he or she otherwise
indicates in forms delivered to the Company: (i) each form will apply to all of his or her Purchase Rights under the Plan, and (ii) a Purchase Right with a lower exercise price (or an earlier-granted Purchase Right, if different Purchase
Rights have identical exercise prices) will be exercised to the fullest possible extent before a Purchase Right with a higher exercise price (or a later-granted Purchase Right if different Purchase Rights have identical exercise prices) will be
exercised. 
 (c)    The Board will have the discretion to structure an Offering so that if the Fair Market Value
of a share of Common Stock on the first Trading Day of a new Purchase Period within that Offering is less than or equal to the Fair Market Value of a share of Common Stock on the Offering Date for that Offering, then (i) that Offering will
terminate immediately as of that first Trading Day, and (ii) the Participants in such terminated Offering will be automatically enrolled in a new Offering beginning on the first Trading Day of such new Purchase Period. 

 

	5.	ELIGIBILITY. 

 (a)    Purchase Rights may be
granted only to Employees of the Company or, as the Board may designate in accordance with Section 2(b), to Employees of a Related Corporation. Except as provided in Section 5(b), an Employee will not be eligible to be granted Purchase
Rights unless, on the Offering Date, the Employee has been in the employ of the Company or the Related Corporation, as the case may be, for such continuous period preceding such Offering Date as the Board may require, but in no event will the
required period of continuous employment be equal to or greater than two years. In addition, the Board may (unless prohibited by law) provide that no Employee will be eligible to be granted Purchase Rights under the Plan unless, on the Offering
Date, such Employee’s customary employment with the Company or the Related Corporation is more than 20 hours per week and more than five months per calendar year or such other criteria as the Board may determine consistent with Section 423
of the Code. The Board may also exclude from participation in the Plan or any Offering Employees who are “highly compensated employees” (within the meaning of Section 414(q) of the Code) of the Company or a Related Corporation or a
subset of such highly compensated employees. 

  
 3 

 (b)    The Board may provide that each person who, during the course
of an Offering, first becomes an Eligible Employee will, on a date or dates specified in the Offering which coincides with the day on which such person becomes an Eligible Employee or which occurs thereafter, receive a Purchase Right under that
Offering, which Purchase Right will thereafter be deemed to be a part of that Offering. Such Purchase Right will have the same characteristics as any Purchase Rights originally granted under that Offering, as described herein, except that: 

(i)    the date on which such Purchase Right is granted will be the “Offering Date” of such Purchase
Right for all purposes, including determination of the exercise price of such Purchase Right; 
 (ii)    the
period of the Offering with respect to such Purchase Right will begin on its Offering Date and end coincident with the end of such Offering; and 

(iii)    the Board may provide that if such person first becomes an Eligible Employee within a specified period of
time before the end of the Offering, he or she will not receive any Purchase Right under that Offering. 

(c)    No Employee will be eligible for the grant of any Purchase Rights if, immediately after any such Purchase
Rights are granted, such Employee owns stock possessing five percent or more of the total combined voting power or value of all classes of stock of the Company or of any Related Corporation. For purposes of this Section 5(c), the rules of
Section 424(d) of the Code will apply in determining the stock ownership of any Employee, and stock which such Employee may purchase under all outstanding Purchase Rights and options will be treated as stock owned by such Employee. 

(d)    As specified by Section 423(b)(8) of the Code, an Eligible Employee may be granted Purchase Rights only
if such Purchase Rights, together with any other rights granted under all Employee Stock Purchase Plans of the Company and any Related Corporations, do not permit such Eligible Employee’s rights to purchase stock of the Company or any Related
Corporation to accrue at a rate which, when aggregated, exceeds US $25,000 of Fair Market Value of such stock (determined at the time such rights are granted, and which, with respect to the Plan, will be determined as of their respective Offering
Dates) for each calendar year in which such rights are outstanding at any time. 
 (e)    Officers of the Company
and any designated Related Corporation, if they are otherwise Eligible Employees, will be eligible to participate in Offerings under the Plan. Notwithstanding the foregoing, the Board may (unless prohibited by law) provide in an Offering that
Employees who are highly compensated Employees within the meaning of Section 423(b)(4)(D) of the Code will not be eligible to participate. 
  

	6.	PURCHASE RIGHTS; PURCHASE PRICE. 

(a)    On each Offering Date, each Eligible Employee, pursuant to an Offering made under the Plan, will be granted a
Purchase Right to purchase up to that number of shares of Common Stock purchasable either with a percentage or with a maximum dollar amount, as designated by the Board, but in either case not exceeding 15% of such Employee’s earnings (as
defined by the Board in each Offering) during the period that begins on the Offering Date (or such later date as the Board determines for a particular Offering) and ends on the date stated in the Offering, which date will be no later than the end of
the Offering. 

  
 4 

 (b)    The Board will establish one or more Purchase Dates during an
Offering on which Purchase Rights granted for that Offering will be exercised and shares of Common Stock will be purchased in accordance with such Offering. 

(c)    In connection with each Offering made under the Plan, the Board may specify (i) a maximum number of
shares of Common Stock that may be purchased by any Participant on any Purchase Date during such Offering, (ii) a maximum aggregate number of shares of Common Stock that may be purchased by all Participants pursuant to such Offering and/or
(iii) a maximum aggregate number of shares of Common Stock that may be purchased by all Participants on any Purchase Date under the Offering. If the aggregate purchase of shares of Common Stock issuable upon exercise of Purchase Rights granted
under the Offering would exceed any such maximum aggregate number, then, in the absence of any Board action otherwise, a pro rata (based on each Participant’s accumulated Contributions) allocation of the shares of Common Stock (rounded down to
the nearest whole share) available will be made in as nearly a uniform manner as will be practicable and equitable. 

(d)    The purchase price of shares of Common Stock acquired pursuant to Purchase Rights will be not less than the
lesser of: 
 (i)    an amount equal to 85% of the Fair Market Value of the shares of Common Stock on the
Offering Date; or 
 (ii)    an amount equal to 85% of the Fair Market Value of the shares of Common Stock on the
applicable Purchase Date. 
  

	7.	PARTICIPATION; WITHDRAWAL; TERMINATION. 

(a)    An Eligible Employee may elect to participate in an Offering and authorize payroll deductions as the means of
making Contributions by completing and delivering to the Company, within the time specified in the Offering, an enrollment form provided by the Company. The enrollment form will specify the amount of Contributions not to exceed the maximum amount
specified by the Board. Each Participant’s Contributions will be credited to a bookkeeping account for such Participant under the Plan and will be deposited with the general funds of the Company except where applicable law or regulations
requires that Contributions be deposited with a third party. If permitted in the Offering, a Participant may begin such Contributions with the first payroll occurring on or after the Offering Date (or, in the case of a payroll date that occurs after
the end of the prior Offering but before the Offering Date of the next new Offering, Contributions from such payroll will be included in the new Offering). If permitted in the Offering, a Participant may thereafter reduce (including to zero) or
increase his or her Contributions. If required under applicable law or regulations or if specifically provided in the Offering, in addition to or instead of making Contributions by payroll deductions, a Participant may make Contributions through the
payment by cash, check or wire transfer prior to a Purchase Date. 

  
 5 

 (b)    During an Offering, a Participant may cease making
Contributions and withdraw from the Offering by delivering to the Company a withdrawal form provided by the Company. The Company may impose a deadline before a Purchase Date for withdrawing. Upon such withdrawal, such Participant’s Purchase
Right in that Offering will immediately terminate and the Company will distribute as soon as practicable to such Participant all of his or her accumulated but unused Contributions and such Participant’s Purchase Right in that Offering shall
thereupon terminate. A Participant’s withdrawal from that Offering will have no effect upon his or her eligibility to participate in any other Offerings under the Plan, but such Participant will be required to deliver a new enrollment form to
participate in subsequent Offerings. 
 (c)    Unless otherwise required by applicable law or regulations,
Purchase Rights granted pursuant to any Offering under the Plan will terminate immediately if the Participant either (i) is no longer an Employee for any reason or for no reason (subject to any post-employment participation period required by
law) or (ii) is otherwise no longer eligible to participate. The Company will distribute as soon as practicable to such individual all of his or her accumulated but unused Contributions. 

(d)    During a Participant’s lifetime, Purchase Rights will be exercisable only by such Participant. Purchase
Rights are not transferable by a Participant, except by will, by the laws of descent and distribution, or, if permitted by the Company, by a beneficiary designation as described in Section 10. 

(e)    Unless otherwise specified in the Offering or required by applicable law or regulations, the Company will
have no obligation to pay interest on Contributions. 
  

	8.	EXERCISE OF PURCHASE RIGHTS. 

(a)    On each Purchase Date, each Participant’s accumulated Contributions will be applied to the purchase of
shares of Common Stock, up to the maximum number of shares of Common Stock permitted by the Plan and the applicable Offering, at the purchase price specified in the Offering. No fractional shares will be issued unless specifically provided for in
the Offering. 
 (b)    Unless otherwise provided in the Offering, if any amount of accumulated Contributions
remains in a Participant’s account after the purchase of shares of Common Stock on the final Purchase Date of an Offering, then such remaining amount will not roll over to the next Offering and will instead be distributed in full to such
Participant after the final Purchase Date of such Offering without interest (unless otherwise required by applicable law or regulations). 

(c)    No Purchase Rights may be exercised to any extent unless the shares of Common Stock to be issued upon such
exercise under the Plan are covered by an effective registration statement pursuant to the Securities Act and the Plan is in material compliance with all applicable federal, state, foreign and other securities and other laws applicable to the Plan.
If on a Purchase Date the shares of Common Stock are not so registered or the Plan is not in such compliance, no Purchase Rights will be exercised on such Purchase Date, and the Purchase Date 

  
 6 

 
will be delayed until the shares of Common Stock are subject to such an effective registration statement and the Plan is in material compliance, except that the Purchase Date will in no event be
more than 27 months from the Offering Date. If, on the Purchase Date, as delayed to the maximum extent permissible, the shares of Common Stock are not registered and the Plan is not in material compliance with all applicable laws and regulations, no
Purchase Rights will be exercised and all accumulated but unused Contributions will be distributed to the Participants without interest. 
  

	9.	COVENANTS OF THE COMPANY. 

The Company will seek to obtain from each federal, state, foreign or other regulatory commission or agency having jurisdiction over the Plan
such authority as may be required to grant Purchase Rights and issue and sell shares of Common Stock thereunder unless the Company determines, in its sole discretion, that doing so would cause the Company to incur costs that are unreasonable. If,
after commercially reasonable efforts, the Company is unable to obtain the authority that counsel for the Company deems necessary for the grant of Purchase Rights or the lawful issuance and sale of Common Stock under the Plan, and at a commercially
reasonable cost, the Company will be relieved from any liability for failure to grant Purchase Rights and/or to issue and sell Common Stock upon exercise of such Purchase Rights. 

 

	10.	DESIGNATION OF BENEFICIARY. 

(a)    The Company may, but is not obligated to, permit a Participant to submit a form designating a beneficiary who
will receive any shares of Common Stock and/or Contributions from the Participant’s account under the Plan if the Participant dies before such shares and/or Contributions are delivered to the Participant. The Company may, but is not obligated
to, permit the Participant to change such designation of beneficiary. Any such designation and/or change must be on a form approved by the Company. 

(b)     If a Participant dies, and in the absence of a valid beneficiary designation, the Company will deliver any
shares of Common Stock and/or Contributions to the executor or administrator of the estate of the Participant. If no executor or administrator has been appointed (to the knowledge of the Company), the Company, in its sole discretion, may deliver
such shares of Common Stock and/or Contributions, without interest, to the Participant’s spouse, dependents or relatives, or if no spouse, dependent or relative is known to the Company, then to such other person as the Company may designate.

  

	11.	ADJUSTMENTS UPON CHANGES IN COMMON STOCK; CORPORATE TRANSACTIONS. 

(a)    In the event of a Capitalization Adjustment, the Board will appropriately and proportionately adjust:
(i) the class(es) and maximum number of securities subject to the Plan pursuant to Section 3(a), (ii) the class(es) and maximum number of securities by which the share reserve is to increase automatically each year pursuant to
Section 3(a), (iii) the class(es) and number of securities subject to, and the purchase price applicable to outstanding Offerings and Purchase Rights, and (iv) the class(es) and number of securities that are the subject of the purchase
limits under each ongoing Offering. The Board will make these adjustments, and its determination will be final, binding and conclusive. 

  
 7 

 (b)    In the event of a Corporate Transaction, then: (i) any
surviving corporation or acquiring corporation (or the surviving or acquiring corporation’s parent company) may assume or continue outstanding Purchase Rights or may substitute similar rights (including a right to acquire the same consideration
paid to the stockholders in the Corporate Transaction) for outstanding Purchase Rights, or (ii) if any surviving or acquiring corporation (or its parent company) does not assume or continue such Purchase Rights or does not substitute
similar rights for such Purchase Rights, then the Participants’ accumulated Contributions will be used to purchase shares of Common Stock (rounded down to the nearest whole share) within ten business days prior to the Corporate Transaction
under the outstanding Purchase Rights, and the Purchase Rights will terminate immediately after such purchase. 
  

	12.	AMENDMENT, TERMINATION OR SUSPENSION OF THE PLAN. 

(a)    The Board may amend the Plan at any time in any respect the Board deems necessary or advisable. However,
except as provided in Section 11(a) relating to Capitalization Adjustments, stockholder approval will be required for any amendment of the Plan for which stockholder approval is required by applicable law, regulations or listing requirements.

 (b)    The Board may suspend or terminate the Plan at any time. No Purchase Rights may be granted under the
Plan while the Plan is suspended or after it is terminated. 
 (c)    Any benefits, privileges, entitlements and
obligations under any outstanding Purchase Rights granted before an amendment, suspension or termination of the Plan will not be materially impaired by any such amendment, suspension or termination except (i) with the consent of the person to
whom such Purchase Rights were granted, (ii) as necessary to comply with any laws, listing requirements, or governmental regulations (including, without limitation, the provisions of Section 423 of the Code and the regulations and other
interpretive guidance issued thereunder relating to Employee Stock Purchase Plans) including without limitation any such regulations or other guidance that may be issued or amended after the date the Plan is adopted by the Board, or (iii) as
necessary to obtain or maintain favorable tax, listing, or regulatory treatment. To be clear, the Board may amend outstanding Purchase Rights without a Participant’s consent if such amendment is necessary to ensure that the Purchase Right
and/or the Plan complies with the requirements of Section 423 of the Code. 
  

	13.	EFFECTIVE DATE OF PLAN. 

 The
Plan will become effective immediately prior to and contingent upon the IPO Date. No Purchase Rights will be exercised unless and until the Plan has been approved by the stockholders of the Company, which approval must be within 12 months before or
after the date the Plan is adopted (or if required under Section 12(a) above, materially amended) by the Board. 
  

	14.	MISCELLANEOUS PROVISIONS. 

(a)    Proceeds from the sale of shares of Common Stock pursuant to Purchase Rights will constitute general funds of
the Company. 
 (b)    A Participant will not be deemed to be the holder of, or to have any of the rights of a
holder with respect to, shares of Common Stock subject to Purchase Rights unless and until the Participant’s shares of Common Stock acquired upon exercise of Purchase Rights are recorded in the books of the Company (or its transfer agent). 

  
 8 

 (c)    The Plan and Offering do not constitute an employment contract.
Nothing in the Plan or in the Offering will in any way alter the at will nature of a Participant’s employment, if applicable, or be deemed to create in any way whatsoever any obligation on the part of any Participant to continue in the employ
of the Company or a Related Corporation, or on the part of the Company or a Related Corporation to continue the employment of a Participant. 

(d)    The provisions of the Plan will be governed by the laws of the State of Delaware without resort to that
state’s conflicts of laws rules. 
 (e)    If any particular provision of the Plan is found to be invalid or
otherwise unenforceable, such provision will not affect the other provisions of the Plan, but the Plan will be construed in all respects as if such invalid provision were omitted. 

(f)    If any provision of the Plan does not comply with applicable law or regulations, such provision shall be
construed in such a manner as to comply with applicable law or regulations. 
  

	15.    DEFINITIONS.	

 As used in the Plan, the following definitions will apply to the capitalized terms
indicated below: 
 (a)    “Board” means the Board of Directors of the Company.

 (b)    “Capital Stock” means each and every class of common stock of the
Company, regardless of the number of votes per share. 
 (c)    “Capitalization
Adjustment” means any change that is made in, or other events that occur with respect to, the Common Stock subject to the Plan or subject to any Purchase Right after the date the Plan is adopted by the Board without the receipt of
consideration by the Company through merger, consolidation, reorganization, recapitalization, reincorporation, stock dividend, dividend in property other than cash, large nonrecurring cash dividend, stock split, liquidating dividend, combination of
shares, exchange of shares, change in corporate structure or other similar equity restructuring transaction, as that term is used in Financial Accounting Standards Board Accounting Standards Codification Topic 718 (or any successor thereto).
Notwithstanding the foregoing, the conversion of any convertible securities of the Company will not be treated as a Capitalization Adjustment. 

(d)    “Code” means the Internal Revenue Code of 1986, as amended, including any
applicable regulations and guidance thereunder. 
 (e)    “Committee” means
a committee of one or more members of the Board to whom authority has been delegated by the Board in accordance with Section 2(c). 

  
 9 

 (f)    “Common Stock” means, as of the IPO
Date, the common stock of the Company, having one vote per share. 
 (g)    “Company”
means Neuronetics, Inc., a Delaware corporation. 
 (h)    “Contributions” means the
payroll deductions and other additional payments specifically provided for in the Offering that a Participant contributes to fund the exercise of a Purchase Right. A Participant may make additional payments into his or her account if specifically
provided for in the Offering, and then only if the Participant has not already had the maximum permitted amount withheld during the Offering through payroll deductions. 

(i)    “Corporate Transaction” means the consummation, in a single transaction or in a
series of related transactions, of any one or more of the following events: 
 (i)    a sale or other
disposition of all or substantially all, as determined by the Board in its sole discretion, of the consolidated assets of the Company and its Subsidiaries; 

(ii)    a sale or other disposition of more than 50% of the outstanding securities of the Company; 

(iii)    a merger, consolidation or similar transaction following which the Company is not the surviving
corporation; or 
 (iv)    a merger, consolidation or similar transaction following which the Company is the
surviving corporation but the shares of Common Stock outstanding immediately preceding the merger, consolidation or similar transaction are converted or exchanged by virtue of the merger, consolidation or similar transaction into other property,
whether in the form of securities, cash or otherwise. 
 (j)    “Director” means a
member of the Board. 
 (k)    “Eligible Employee” means an Employee who meets the
requirements set forth in the document(s) governing the Offering for eligibility to participate in the Offering, provided that such Employee also meets the requirements for eligibility to participate set forth in the Plan. 

(l)    “Employee” means any person, including an Officer or Director, who is
“employed” for purposes of Section 423(b)(4) of the Code by the Company or a Related Corporation. However, service solely as a Director, or payment of a fee for such services, will not cause a Director to be considered an
“Employee” for purposes of the Plan. 
 (m)    “Employee Stock Purchase
Plan” means a plan that grants Purchase Rights intended to be options issued under an “employee stock purchase plan,” as that term is defined in Section 423(b) of the Code. 

(n)    “Exchange Act” means the Securities Exchange Act of 1934, as amended and the
rules and regulations promulgated thereunder. 

  
 10 

 (o)    “Fair Market Value” means, as of any
date, the value of the Common Stock determined as follows: 
 (i)    If the Common Stock is listed on any
established stock exchange or traded on any established market, the Fair Market Value of a share of Common Stock will be the closing sales price for such stock as quoted on such exchange or market (or the exchange or market with the greatest volume
of trading in the Common Stock) on the date of determination, as reported in such source as the Board deems reliable. Unless otherwise provided by the Board, if there is no closing sales price for the Common Stock on the date of determination, then
the Fair Market Value will be the closing sales price on the last preceding date for which such quotation exists. 

(ii)    In the absence of such markets for the Common Stock, the Fair Market Value will be determined by the Board
in good faith in compliance with applicable laws and regulations and in a manner that complies with Sections 409A of the Code 

(iii)    Notwithstanding the foregoing, for any Offering that commences on the IPO Date, the Fair Market Value of
the shares of Common Stock on the Offering Date will be the price per share at which shares are first sold to the public in the Company’s initial public offering as specified in the final prospectus for that initial public offering. 

(p)    “IPO Date” means the date of the underwriting agreement between the Company
and the underwriters managing the initial public offering of the Common Stock, pursuant to which the Common Stock is priced for the initial public offering. 

(q)    “Offering” means the grant to Eligible Employees of Purchase Rights, with the
exercise of those Purchase Rights automatically occurring at the end of one or more Purchase Periods. The terms and conditions of an Offering will generally be set forth in the “Offering Document” approved by the Board for
that Offering. 
 (r)    “Offering Date” means a date selected by the Board for an
Offering to commence. 
 (s)    “Officer” means a person who is an officer
of the Company or a Related Corporation within the meaning of Section 16 of the Exchange Act. 

(t)    “Participant” means an Eligible Employee who holds an outstanding Purchase
Right. 
 (u)    “Plan” means this Neuronetics, Inc. 2018 Employee Stock Purchase
Plan. 
 (v)    “Purchase Date” means one or more dates during an Offering
selected by the Board on which Purchase Rights will be exercised and on which purchases of shares of Common Stock will be carried out in accordance with such Offering. 

(w)    “Purchase Period” means a period of time specified within an Offering, generally
beginning on the Offering Date or on the first Trading Day following a Purchase Date, and ending on a Purchase Date. An Offering may consist of one or more Purchase Periods. 

  
 11 

 (x)    “Purchase Right” means an option
to purchase shares of Common Stock granted pursuant to the Plan. 
 (y)    “Related
Corporation” means any “parent corporation” or “subsidiary corporation” of the Company whether now or subsequently established, as those terms are defined in Sections 424(e) and (f), respectively, of the Code.

 (z)    “Securities Act” means the Securities Act of 1933, as amended. 

(aa)    “Trading Day” means any day on which the exchange(s) or market(s) on which
shares of Common Stock are listed, including but not limited to the NYSE, Nasdaq Global Select Market, the Nasdaq Global Market, the Nasdaq Capital Market or any successors thereto, is open for trading. 

  
 12EX-10.13

 Exhibit 10.13 

FORM OF NON-QUALIFIED STOCK OPTION AGREEMENT 

FOR THE 
 NEURONETICS,
INC. 
 AMENDED AND RESTATED 2003 STOCK INCENTIVE PLAN 

This Non-Qualified Stock Option Agreement (this “Agreement”) consists of the following: the
Grant and Award Agreement (below), an Exercise Notice designated as Exhibit A and an Investment Representation Statement designated as Exhibit B, all of which are integral parts of one document that, together with the Neuronetics, Inc. Amended and
Restated 2003 Stock Incentive Plan (the “Plan”), a copy of which is attached and designated as Exhibit C, defines the rights and obligations of the parties. 

GRANT AND AWARD AGREEMENT 

1.    Grant of Option and Exercise Price. Subject to the terms and conditions set forth herein and in the Plan,
Neuronetics, Inc. (the “Company”) hereby grants to [            ] (“Optionee”), effective [            ] (the
“Grant Date”), a non-qualified stock option (the “Option”) to purchase up to [            ] shares of Common Stock of the Company
at an exercise price of $[            ] per share (the “Exercise Price”). The Option is intended to be a non-qualified stock option as
defined under section 422 of the Code and any regulations promulgated thereunder. 
 2.    Vesting of Option. The
Option shall vest as follows: (a) 25% of the shares of Common Stock subject to the Option on the first anniversary of the commencement of Optionee’s employment with the Company or its Subsidiary and then (b) 1/36th of the remaining unvested shares of Common Stock subject to the Option each month thereafter. 

3.    Time of Exercise. Subject to the vesting schedule in Section 2, Optionee may exercise all or some
portion of the Option for any whole number of shares from time to time up until the tenth anniversary of the Grant Date. Upon the tenth anniversary of the Grant Date, Optionee’s right to exercise the Option shall terminate absolutely. 

4.    Payment for Shares of Common Stock. Within three (3) days of the exercise of an Option and before
delivery of the shares of Common Stock, full payment for shares of Common Stock purchased upon the exercise of such Option shall be made in cash, or, subject to the approval of the Committee, by (a) surrendering shares of Common Stock that have
an aggregate Fair Market Value equal to the aggregate Exercise Price and that have been held by Optionee for at least six months or (b) delivery of a properly executed exercise notice, together with irrevocable instructions to a
Company-designated broker to promptly deliver to the Company the amount of sale or loan proceeds required to pay the aggregate Exercise Price. 

 5.    Manner of Exercise. 

(A)    The Option shall be exercised by delivery of an exercise notice in the form attached hereto as Exhibit A (the
“Exercise Notice”), which shall state Optionee’s election to exercise the Option, the whole number of shares with respect to which the Option is being exercised and such other representations and agreements as may be required by the
Company and contained in the Exercise Notice. The Exercise Notice shall be accompanied within three (3) days by payment of the aggregate Exercise Price in a form permitted under Section 4 hereof. The Option shall be deemed to be exercised
upon receipt by the Company of such fully-executed Exercise Notice accompanied by payment of the aggregate Exercise Price within three (3) days of such exercise. The Exercise Notice shall be irrevocable once given. 

(B)    In the event the shares issuable upon the exercise of the Option have not been registered under the Securities Act
of 1933, as amended (the “Securities Act”), at the time the Option is exercised, Optionee shall, concurrently with the exercise of all or any portion of the Option, deliver to the Company an Investment Representation Statement in the form
attached hereto as Exhibit B, or take such other action to comply with the securities laws of the United States or of any state, as the Company shall determine to be necessary. 

6.    Issuance of Certificates. As promptly as the Company determines is reasonably practicable after the exercise
of the Option, a certificate for the shares of Common Stock issuable on the exercise of the Option shall be delivered to Optionee or to his or her personal representative, heir or legatee. 

7.    Transferability. 

(A)    The Option may not be transferred or assigned by Optionee except by will or the laws of descent and distribution
or be exercised other than by Optionee or, in the case of his or her death, by his or her personal representative, heir or legatee. 

(B)    Prior to the Company becoming Publicly Traded, the shares acquired upon the exercise of the Option may not be
transferred except in accordance with the terms of this Agreement or by will or the laws of descent and distribution. Each certificate evidencing the shares acquired upon exercise of the Option shall bear the legend set forth in the Investment
Representation Statement. 
 8.    Taxes. Optionee shall be responsible to make appropriate provision for all
taxes required to be withheld in connection with any Option, the exercise thereof and the transfer of the shares of Common Stock. Such responsibility shall extend to all applicable federal, state, local or foreign withholding taxes. The Company
shall have the right to retain the number of shares of Common Stock whose aggregate Fair Market Value equals the amount to be withheld in satisfaction of the applicable withholding taxes. 

9.    Termination of Employment. If Optionee’s employment with the Company or its Subsidiary or Affiliate is
terminated by reason of death or Disability, then all vested Options may be exercised for twelve (12) months from the date of such termination or until the expiration of the term of the Option, as provided in Section 3 above,
whichever period is shorter. If Optionee’s employment with the Company or its Subsidiary or Affiliate is 

  
 - 2 - 

 
terminated for Cause, as determined by the Committee, then any Options which are unexercised shall terminate on the date of such termination, or notice of such termination, if earlier. If
Optionee’s employment with the Company or its Subsidiary or Affiliate is terminated for any reason other than death, Disability or Cause, all vested Options may be exercised for three months from the date of such termination or until the
expiration of the term of the Option, whichever period is shorter. Any unvested Options shall be forfeited as of the date Optionee’s employment with the Company or its Subsidiary or Affiliate is terminated for any reason. Additionally, any
vested Option that is not exercised within the applicable period of time, as provided in this Section 9, after Optionee’s termination of employment shall be irrevocably forfeited. 

10.    Repurchase by Company. If Optionee’s employment with the Company or its Subsidiary or Affiliate is
terminated prior to the Company’s becoming Publicly Traded, the Company may repurchase any or all shares of Common Stock which have been issued to Optionee pursuant to this Agreement (i) at the Fair Market Value of such shares on the date
of such termination if such termination is not for Cause or (ii) if such termination is for Cause, at the lesser of: (A) the Fair Market Value of such shares on the date of such termination or (B) the price Optionee paid for the
shares (subject to any adjustment as provided in Section 10 of the Plan). If the Company chooses to exercise its right to repurchase under this Section 10, it shall send Optionee written notice of its intent to do so no more than 30 days
after such termination. If after Optionee’s employment with the Company or its Subsidiary or Affiliate is terminated, Optionee and/or his or her beneficiary acquires additional shares of Common Stock pursuant to an exercise under this Agreement
prior to the Company’s becoming Publicly Traded, the Company may repurchase any or all shares of Common Stock so acquired at the Fair Market Value of such shares on the date of exercise, by providing written notice of its intent to do so within
30 days of such exercise. 
 11.    Right of First Refusal. 

(A)    Exercise of Right. If Optionee desires to transfer all or any part of the shares acquired pursuant to this
Agreement to any person other than the Company (an “Offeror”), Optionee shall: (i) obtain in writing an irrevocable and unconditional bona fide offer (the “Offer”) for the purchase thereof from the Offeror; and
(ii) give written notice (the “Option Notice”) to the Company setting forth Optionee’s desire to transfer such shares, which Option Notice shall be accompanied by a photocopy of the Offer and shall set forth at least the name and
address of the Offeror and the price and terms of the Offer. Upon receipt of the Option Notice, the Company shall have an assignable option to purchase any or all of such shares (the “Company Option Shares”) specified in the Option Notice,
such option to be exercisable by giving, within 30 days after receipt of the Option Notice, a written counter-notice to Optionee. If the Company elects to purchase any or all of such Company Option Shares, it shall be obligated to purchase, and
Optionee shall be obligated to sell to the Company, such Company Option Shares at the price and terms indicated in the Offer within 30 days from the date of delivery by the Company of such counter-notice. 

(B)    Sale of Option Shares to Offeror. Optionee may, for 60 days after the expiration of the 30-day option period as set forth in Section 11(A), sell to the Offeror, pursuant to the terms of the Offer, any or all of such Company Option Shares not purchased or

  
 - 3 - 

 
agreed to be purchased by the Company or its assignee; provided, however, that Optionee shall not sell such Company Option Shares to such Offeror if such Offeror is a competitor of the Company
and the Company gives written notice to Optionee, within 30 days of its receipt of the Option Notice, stating that Optionee shall not sell his or her Company Option Shares to such Offeror; and provided, further, that prior to the sale of such
Company Option Shares to an Offeror, such Offeror shall execute an agreement with the Company pursuant to which such Offeror agrees to be subject to the restrictions set forth in this Section 11. If any or all of such Company Option Shares are
not sold pursuant to an Offer within the time permitted above, the unsold Company Option Shares shall remain subject to the terms of this Section 11. 

(C)    Failure to Deliver Option Shares. If Optionee fails or refuses to deliver on a timely basis duly endorsed
certificates representing Company Option Shares to be sold to the Company or its assignee pursuant to this Section 11, the Company shall have the right to deposit the purchase price for such Company Option Shares in a special account with any
bank or trust company, giving notice of such deposit to Optionee, whereupon such Company Option Shares shall be deemed to have been purchased by the Company. All such monies shall be held by the bank or trust company for the benefit of Optionee. All
monies deposited with the bank or trust company but remaining unclaimed for two years after the date of deposit shall be repaid by the bank or trust company to the Company on demand, and Optionee shall thereafter look only to the Company for
payment. 
 (D)    Expiration of Company’s Right of First Refusal. The first refusal rights of the Company
set forth above shall remain in effect until such time, if ever, as the Company becomes Publicly Traded, at which time the refusal rights of the Company set forth herein will automatically expire. 

12.    Lock-up Agreement. Optionee agrees that in connection with
the Company’s first underwritten public offering of Common Stock, upon the request of the Company or the principal underwriter managing such public offering, the shares acquired pursuant to this Agreement may not be sold, offered for sale or
otherwise disposed of, including any sale pursuant to Rule 144, without the prior written consent of the Company or such underwriter, as the case may be, for a period of up to 180 days after the effectiveness of the registration statement filed in
connection with such offering. 
 13.    Rights Prior to Exercise. Neither Optionee nor Optionee’s personal
representative, heir or legatee shall have any of the rights of a stockholder with respect to any Common Stock until the date of the issuance to him or her of a certificate for such Common Stock as provided herein. 

14.    Amendments. The Committee may from time to time amend the terms of this Agreement to the extent it deems
appropriate to carry out the terms and provisions of the Plan; provided that any amendment adverse to Optionee shall be effective only if consented to by Optionee in writing. 

15.    Interpretation of Agreement and Plan. The Committee shall have sole power to interpret and construe any
provisions of this Agreement or the Plan. Any such interpretation or construction made by the Committee shall be final and conclusive and, insofar 

  
 - 4 - 

 
as possible, shall be consistent with the requirements of a non-qualified stock option. In the event of any differences between the provisions of this
Agreement and the terms of the Plan, the terms of the Plan will control. 
 16.    Option Not to Affect
Employment. The Option granted hereunder shall not confer upon Optionee any right to continue in the employment of the Company or its Subsidiary or Affiliate. 

17.    Miscellaneous. The captions of this Agreement are not part of the provisions hereof and shall have no force
or effect. All capitalized terms not defined in this Agreement shall have the meaning set forth in the Plan unless the context clearly requires an alternative meaning. The invalidity or unenforceability of any provision of this Agreement shall not
affect the validity or enforceability of any other provision of this Agreement. 
 18.    Securities Laws. The
Committee may from time to time impose any conditions on the exercise of the Option as it deems necessary or advisable to ensure that all rights granted under the Plan satisfy the requirements of applicable securities laws. Such conditions may
include, without limitation, the partial or complete suspension of the right to exercise the Option or trade the shares issued upon exercise. 

19.    Notices. All notices or other communications given hereunder shall be in writing, shall be sent by
registered or certified mail, return receipt requested, postage prepaid, or by hand delivery or by expedited delivery service, delivery charges prepaid and with acknowledged receipt of delivery. A notice or other communication shall be deemed given
on the date of acceptance or refusal of acceptance shown on such receipt, and shall be addressed, as the case may be to Optionee and to the Company at the following applicable address: 

(A)    If to Optionee, to the address specified by Optionee below. 

(B)    If to the Company, to: 

Neuronetics, Inc. 

3222 Phoenixville Pike 

Malvern, PA 19355 

Attention: Chief Executive Officer 

Any party may, by notice given in compliance with this Section, change its address for all subsequent notices. 

20.    Adjustments for Changes in Capital Structure. If there shall be any change in the Common Stock of the
Company through merger, consolidation, reorganization, recapitalization, stock dividend, stock split, combination or exchange of shares, or the like, the restrictions contained in this Agreement shall apply with equal force to additional and/or
substitute securities, if any, received by Optionee in exchange for, or by virtue of his or her ownership of, shares acquired pursuant to this Agreement, except as otherwise determined by the Board. 

  
 - 5 - 

 21.    Entire Agreement. This Agreement constitutes the entire
agreement of the parties with respect to the subject matter hereof. This Agreement supersedes all prior discussions, negotiations, understandings, commitments and agreements with respect to such matters. 

22.    Governing Law. To the extent not preempted by federal law, this Agreement shall be governed by and construed
in accordance with the laws of the State of Delaware without reference to rules relating to conflict of laws. 
  

					
		  		  	 NEURONETICS, INC.

			
	 Dated:
                                    
	  		  	 By:
                                         
                           

		  		  	             Name:

		  		  	             Title:

			
	 Dated:
                                    
	  		  	
                          
                              

		  		  	 EMPLOYEE NAME

  
 - 6 - 

 Exhibit A 

EXERCISE NOTICE 
 FOR

 NEURONETICS, INC. AMENDED AND RESTATED 2003 STOCK INCENTIVE PLAN 

Neuronetics, Inc. 
 3222 Phoenixville Pike 

Malvern, PA 19355 
 Attention: Chief Executive Officer 

2.    Exercise of Option. Effective as of
today,                    , 20         (the “Exercise Date”) the undersigned (“Optionee”)
hereby elects to exercise Optionee’s option (the “Option”) to purchase                     shares of the Common Stock (the
“Shares”) of Neuronetics, Inc. (the “Company”), under and pursuant to the Neuronetics, Inc. Amended and Restated 2003 Stock Incentive Plan (the “Plan”) and the Non-Qualified Stock
Option Agreement dated                 (the “Option Agreement”). 

3.    Delivery of Payment. Optionee shall deliver to the Company the full exercise price of the Shares, as set
forth in the Option Agreement within three (3) days of the Exercise Date. 
 4.    Representations of
Optionee. Optionee acknowledges that Optionee has received, read and understands the Plan and the Option Agreement and agrees to abide by and be bound by the terms and conditions contained therein. 

5.    Rights as Stockholder. Until the issuance of the Shares, no right to vote or receive dividends or any other
rights as a stockholder shall exist with respect to the Shares, notwithstanding the exercise of the Option. The Shares shall be issued to Optionee as soon as practicable after the Option is exercised. No adjustment shall be made for a dividend or
other right for which the record date is prior to the date of issuance. 
 6.    Company’s Right of First
Refusal. Before any Shares held by Optionee or any transferee may be sold or otherwise transferred, the Company or its assignee(s) shall have a right of first refusal to purchase the Shares on the terms and conditions set forth in the Option
Agreement. 

  
 A - 1 

 7.    Terms of the Plan and the Option Agreement Govern. Optionee
specifically acknowledges that the Option and any Shares acquired upon exercise of the Option are subject to all of the terms and conditions of the Plan and the Option Agreement. 

8.    Tax Consultation. Optionee understands that Optionee may suffer adverse tax consequences as a result of
Optionee’s purchase or disposition of the Shares. Optionee represents that Optionee has consulted with all tax consultants Optionee deems advisable in connection with the purchase or disposition of the Shares and that Optionee is not relying on
the Company or the Committee for any tax advice. 
 9.    Restrictive Legends and Stop-Transfer Orders. 

(A)    Legends. Optionee understands and agrees that the Company shall cause the legend set forth below or a
legend substantially equivalent thereto to be placed upon any certificate(s) evidencing ownership of the Shares together with any other legends that may be required by the Company or by state or federal securities laws: 

“THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE BEEN ACQUIRED FOR INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF
1933, AS AMENDED (THE “ACT”), OR ANY APPLICABLE STATE SECURITIES LAWS. THESE SECURITIES MAY NOT BE SOLD OR TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR AN EXEMPTION THEREFROM UNDER THE ACT. ADDITIONALLY, THESE SECURITIES ARE
SUBJECT TO A REPURCHASE RIGHT AND RIGHT OF FIRST REFUSAL IN FAVOR OF NEURONETICS, INC. SPECIFIED IN THE NON-QUALIFIED STOCK OPTION AGREEMENT (THE “OPTION AGREEMENT”) ISSUED PURSUANT TO THE
NEURONETICS, INC. AMENDED AND RESTATED 2003 STOCK INCENTIVE PLAN (THE “PLAN”) BETWEEN NEURONETICS, INC. AND THE OTHER PARTY THERETO (AS EACH OF THE SAME MAY BE AMENDED AND/OR RESTATED FROM TIME TO TIME). 

ANY ATTEMPT TO TRANSFER THESE SHARES, OTHER THAN BY WILL OR THE LAWS OF DESCENT AND DISTRIBUTION, WITHOUT COMPLYING WITH THE TERMS OF THE PLAN
OR THE OPTION AGREEMENT, OR ANY SUCCESSOR THERETO, SHALL BE NULL AND VOID.” 
 (B)    Stop-Transfer Orders.
Optionee agrees that, in order to ensure compliance with the restrictions referred to herein, the Company may issue appropriate “stop transfer” instructions to its transfer agent, if any, and that, if the Company transfers its own
securities, it may make appropriate notations to the same effect in its own records. 
 (C)    Refusal to
Transfer. The Company shall not be required (i) to transfer on its books any Shares that have been sold or otherwise transferred in violation of any of the provisions of this Exercise Notice or (ii) to treat as owner of such Shares or
to accord the right to vote or pay dividends to any purchaser or other transferee to whom such Shares shall have been so transferred or as to which the Company has not received notice. 

  
 A - 2 

 10.    Entire Agreement. The Plan and Option Agreement are
incorporated herein by reference. Unless otherwise defined herein, the terms contained in the Exercise Notice shall have the same meaning as defined in the Plan and/or the Option Agreement. This Exercise Notice, the Plan and the Option Agreement
(and the Exhibits thereto) constitute the entire agreement of the parties with respect to the subject matter hereof and supersede in their entirety all prior undertakings and agreements of the Company and Optionee with respect to the subject matter
hereof, and may not be modified adversely to Optionee’s interest except by means of a writing signed by the Company and Optionee. In the event of a conflict between the terms and conditions of this Exercise Notice and the Plan, the terms and
conditions of the Plan shall prevail. 
  

					
	Submitted by:	 		  	Accepted by:
			
		 		  	NEURONETICS, INC.
			
	 	 		  	By:                                     
                                         
          

  
 A - 3 

 Exhibit B 

INVESTMENT REPRESENTATION STATEMENT 

FOR 
 NEURONETICS, INC.

 AMENDED AND RESTATED 2003 STOCK INCENTIVE PLAN 

Optionee:                        
                         

Shares:                        
             shares of Common Stock of Neuronetics, Inc. (the “Shares”) 

Amount Paid:                       
                   

Date:                         
                               

In connection with the purchase of the above-listed Shares, the undersigned Optionee represents to the Company the following: 

1.    Optionee is aware of the Company’s business affairs and financial condition and has acquired sufficient
information about the Company to reach an informed and knowledgeable decision to acquire the Shares. Optionee is acquiring these Shares for investment for Optionee’s own account only and not with a view to, or for resale in connection with, any
“distribution” thereof within the meaning of the Securities Act of 1933, as amended (the “Securities Act”). 

2.    Optionee acknowledges and understands that the Shares constitute “restricted securities” under the
Securities Act and have not been registered under the Securities Act in reliance upon a specific exemption therefrom, which exemption depends upon, among other things, the bona fide nature of Optionee’s investment intent as expressed herein. In
this connection, Optionee understands that, in the view of the Securities and Exchange Commission, the statutory basis for such exemption may be unavailable if Optionee’s representation was predicated solely upon a present intention to hold
these Shares for the minimum capital gains period specified under tax statutes, for a deferred sale, for or until an increase or decrease in the market price of the Shares or for a period of one year or any other fixed period in the future. Optionee
further understands that the Shares must be held indefinitely unless they are subsequently registered under the Securities Act or an exemption from such registration is available. Optionee further acknowledges and understands that the Company is
under no obligation to register the Shares. Optionee understands that the certificate evidencing the Shares will be imprinted with a legend which prohibits the transfer of the Shares unless they are registered or such registration is not required in
the opinion of counsel satisfactory to the Company and with any other legend required under applicable state securities laws. 

  
 B - 1 

 3.    Optionee is familiar with the provisions of Rule 701 and Rule 144, each
promulgated under the Securities Act, which, in substance, permit limited public resale of “restricted securities” acquired, directly or indirectly from the issuer thereof, in a non-public offering
subject to the satisfaction of certain conditions. Rule 701 provides that if the issuer qualifies under Rule 701 at the time of the grant of the Option to Optionee, the exercise will be exempt from registration under the Securities Act. In the event
the Company becomes subject to the reporting requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, ninety (90) days thereafter (or such longer period as any market stand-off
agreement may require) the Shares exempt under Rule 701 may be resold, subject to the satisfaction of certain of the conditions specified by Rule 144, including: (a) the resale being made through a broker in an unsolicited “broker’s
transaction” or in transactions directly with a market maker (as said term is defined under the Securities Exchange Act of 1934); and, in the case of an affiliate, (b) the availability of certain public information about the Company;
(c) the amount of Shares being sold during any three month period not exceeding the limitations specified in Rule 144(e); and (d) the timely filing of a Form 144, if applicable. 

In the event that the Company does not qualify under Rule 701 at the time of grant of the Option, then the Shares may be resold in certain
limited circumstances subject to the provisions of Rule 144, which requires the resale to occur after a specified holding period. 

4.    Optionee further understands that in the event all of the applicable requirements of Rule 701 or 144 are not
satisfied, registration under the Securities Act, compliance with Regulation A or some other registration exemption will be required; and that, notwithstanding the fact that Rules 144 and 701 are not exclusive, the Staff of the Securities and
Exchange Commission has expressed its opinion that persons proposing to sell private placement securities other than in a registered offering and otherwise than pursuant to Rules 144 or 701 will have a substantial burden of proof in establishing
that an exemption from registration is available for such offers or sales, and that such persons and their respective brokers who participate in such transactions do so at their own risk. Optionee understands that no assurances can be given that any
such other registration exemption will be available in such event. 
  

			
	Date:                       	  	 Signature of Optionee:
                                         
       

		  	

  
 B - 2 

 Exhibit C 

NEURONETICS, INC. 

AMENDED AND RESTATED 2003 STOCK INCENTIVE PLAN 

  
 C - 1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00284-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00284-of-00352.parquet"}]]